John Liddicoat

Endovate is a mission-driven medical device startup dedicated to transforming stroke care through rapid, pre-hospital detection of large vessel occlusion (LVO) strokes, one of the leading causes of stroke-related death and disability. Founded by a multidisciplinary team with clinical, technical, and entrepreneurial expertise—and backed by education from Northwestern University’s Kellogg, Feinberg, and McCormick—Endovate is uniquely positioned to bring this vision to life.